United Therapeutics (UTHR) Prepaid Assets (2009 - 2026)
United Therapeutics' (UTHR) quarterly Prepaid Assets came in at $317.3 million in Q2 2026, up 38.14% year-over-year from $229.7 million in Q2 2025, and up 39.17% quarter-over-quarter from $228.0 million in Q1 2026.
Analysis
United Therapeutics (UTHR) Prepaid Assets (2009 - 2026) Analysis & Trends
United Therapeutics has disclosed Prepaid Assets across 18 years of filings, most recently posting $317.3 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 38.14% year-over-year to $317.3 million; the TTM figure through Jun 2026 stood at $317.3 million (up 38.14% YoY), while the FY2025 annual figure was $248.9 million, up 46.67% from the prior year.
- Prepaid Assets came in at $317.3 million for Q2 2026 at United Therapeutics, up from $228.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $317.3 million in Q2 2026 to a low of $60.2 million in Q1 2022.
- Average Prepaid Assets over 5 years is $183.2 million, with a median of $177.5 million recorded in 2024.
- Year-over-year, Prepaid Assets surged 118.33% in 2022 and fell 24.18% in 2023.
- Over 5 years, Prepaid Assets stood at $219.2 million in 2022, then retreated by 24.18% to $166.2 million in 2023, then increased by 2.11% to $169.7 million in 2024, then surged by 46.67% to $248.9 million in 2025, then climbed by 27.48% to $317.3 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $317.3 million in Q2 2026, $228.0 million in Q1 2026, and $248.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 317.30 Mn |
| Mar 31, 2026 | 228.00 Mn |
| Dec 31, 2025 | 248.90 Mn |
| Sep 30, 2025 | 252.20 Mn |
| Jun 30, 2025 | 229.70 Mn |
| Mar 31, 2025 | 131.10 Mn |
| Dec 31, 2024 | 169.70 Mn |
| Sep 30, 2024 | 185.40 Mn |
| Jun 30, 2024 | 220.80 Mn |
| Mar 31, 2024 | 113.40 Mn |
| Dec 31, 2023 | 166.20 Mn |
| Sep 30, 2023 | 220.50 Mn |
| Jun 30, 2023 | 158.40 Mn |
| Mar 31, 2023 | 92.60 Mn |
| Dec 31, 2022 | 219.20 Mn |
| Sep 30, 2022 | 118.10 Mn |
| Jun 30, 2022 | 165.80 Mn |
| Mar 31, 2022 | 60.20 Mn |
| Dec 31, 2021 | 100.40 Mn |
| Sep 30, 2021 | 76.00 Mn |